|
Oct 1
|
Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases
|
|
Jul 29
|
Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags
|
|
Jul 27
|
In spite of recent selling, insiders still control 53% of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)
|
|
Jun 5
|
Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies
|
|
May 6
|
Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)
|
|
May 4
|
Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
|
|
May 3
|
Amneal Reports First Quarter 2024 Financial Results
|
|
Feb 27
|
Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203
|
|
Jan 25
|
Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203
|
|
Jan 10
|
Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension
|
|
Dec 21
|
Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference
|
|
Dec 15
|
Amneal Announces Move to Nasdaq
|
|
Dec 7
|
Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone)
|
|
Dec 1
|
Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules
|
|
Nov 27
|
Should You Be Excited About Amneal Pharmaceuticals, Inc.'s (NYSE:AMRX) 20% Return On Equity?
|
|
Nov 10
|
Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?
|
|
Nov 8
|
Amneal Pharmaceuticals, Inc. (NYSE:AMRX) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
Amneal (AMRX) Reports Q3 Earnings: What Key Metrics Have to Say
|
|
Nov 7
|
Amneal Pharmaceuticals Inc (AMRX) Reports 14% Increase in Q3 2023 Net Revenue
|
|
Nov 7
|
Amneal Reports Third Quarter 2023 Financial Results
|